基于18F-FDG PET/CT影像组学预测中高危前列腺癌的预后及雄激素剥夺治疗反应
回顾性分析104例治疗前接受18F-FDG PET/CT的中高危前列腺癌患者,按72例训练集和32例测试集建模;影像组学模型A在训练集和测试集的AUC分别为0.844和0.804,联合影像组学评分与肿瘤-肝脏比值的列线图在测试集AUC为0.827;内分泌治疗亚组和转移亚组的AUC分别为0.845和0.807。
要点
- 模型A由8个影像组学特征构成,训练集AUC 0.844、测试集AUC 0.804。
- 影像组学列线图联合影像组学评分与肿瘤-肝脏比值,测试集AUC 0.827。
- 内分泌治疗亚组和转移亚组的模型AUC分别为0.845和0.807。
核心结论
- 18F-FDG PET/CT影像组学列线图可用于预测中高危前列腺癌患者的预后,提示其具有临床应用潜力。
研究设计与样本
- 回顾性分析104例治疗前接受18F-FDG PET/CT的中高危前列腺癌患者,分为训练集72例和测试集32例;采用多变量逻辑回归结合交叉验证构建影像组学模型A和基于集成学习的模型B,并针对雄激素剥夺治疗亚组和转移亚组分别建模。
诊断标准与关键数值
- 模型A整合8个影像组学特征,训练集AUC 0.844,测试集AUC 0.804。
- 联合模型A的影像组学评分与肿瘤-肝脏比值的列线图在测试集AUC 0.827。
- 内分泌治疗亚组的PET/CT影像组学模型AUC 0.845,转移性前列腺癌亚组AUC 0.807。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aims to predict intermediate to high-risk prostate cancer (PCa) prognosis based on 18-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) radiomics. Additionally, subgroup analysis will be performed on the androgen deprivation therapy (ADT) group and the metastatic PCa group.
MATERIALS AND METHODS: In the retrospective analysis of 104 intermediate to high-risk PCa patients who underwent 18F-FDG PET/CT prior to treatment. The data set was divided into a training set (n = 72) and a testing set (n = 32). Two different PET/CT models were constructed using multivariate logistic regression with cross-validation: radiomics model A and an alternative ensemble learning-based model B. The superior model was then selected to develop a radiomics nomogram. Separate models were also developed for the ADT and metastatic PCa subgroups.
RESULTS: Model A, which integrates eight radiomics features showed excellent performance with an area under curve (AUC) of 0.844 in the training set and 0.804 in the testing set. The radiomics nomogram incorporating the radiomics score (radscore) from model A and the tumor-to-liver ratio (TLR) showed good prognostic accuracy in the testing set with an AUC of 0.827. In the subgroup analyses for endocrine therapy and metastatic cancer, the PET/CT radiomics model showed AUCs of 0.845 and 0.807 respectively, suggesting its potential effectiveness.
CONCLUSION: The study establishes the utility of the 18F-FDG PET/CT radiomics nomogram in predicting the prognosis of intermediate to high-risk PCa patients, indicating its potential for clinical application.
引用
- Qiao J, Liu B, Xin J, et al. Prediction of Prognosis and Response to Androgen Deprivation Therapy in Intermediate to High-Risk Prostate Cancer Using 18F-FDG PET/CT Radiomics. Acad Radiol. 2024. PMID: 39019687. doi:10.1016/j.acra.2024.06.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。